Emergent BioSolutions
EBS
#7959
Rank
NZ$0.64 B
Marketcap
NZ$12.56
Share price
-3.00%
Change (1 day)
-1.01%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): NZ$0.10 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$0.64 Billion. In 2025 the company made an earning of NZ$0.24 Billion, an increase over its 2024 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.10 B-58.26%
2025 NZ$0.24 B-297.64%
2024 -NZ$0.13 Billion-88.82%
2023 -NZ$1.12 Billion242.73%
2022 -NZ$0.33 Billion-153.8%
2021 NZ$0.60 B-20.43%
2020 NZ$0.75 B278.02%
2019 NZ$0.20 B27.11%
2018 NZ$0.15 B-27.12%
2017 NZ$0.21 B17.21%
2016 NZ$0.18 B0.45%
2015 NZ$0.18 B73.51%
2014 NZ$0.10 B41.36%
2013 NZ$74.86 M35.2%
2012 NZ$55.37 M0.4%
2011 NZ$55.15 M-56.46%
2010 NZ$0.12 B76.73%
2009 NZ$71.67 M32.94%
2008 NZ$53.91 M-5.62%
2007 NZ$57.13 M
2005 NZ$82.71 M269.89%
2004 NZ$22.36 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.28 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.70 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.28 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$20.21 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$35.62 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.54 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.92 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel